CA1337115C - Vaccin contre les maladies apparentees a la rage - Google Patents

Vaccin contre les maladies apparentees a la rage

Info

Publication number
CA1337115C
CA1337115C CA000573293A CA573293A CA1337115C CA 1337115 C CA1337115 C CA 1337115C CA 000573293 A CA000573293 A CA 000573293A CA 573293 A CA573293 A CA 573293A CA 1337115 C CA1337115 C CA 1337115C
Authority
CA
Canada
Prior art keywords
rabies
virus
protein
cvs
cfa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000573293A
Other languages
English (en)
Inventor
Bernhard Dietzschold
Hilary Koprowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wistar Institute of Anatomy and Biology
Original Assignee
Wistar Institute of Anatomy and Biology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wistar Institute of Anatomy and Biology filed Critical Wistar Institute of Anatomy and Biology
Application granted granted Critical
Publication of CA1337115C publication Critical patent/CA1337115C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
CA000573293A 1987-07-30 1988-07-28 Vaccin contre les maladies apparentees a la rage Expired - Fee Related CA1337115C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7963987A 1987-07-30 1987-07-30
US079,639 1987-07-30

Publications (1)

Publication Number Publication Date
CA1337115C true CA1337115C (fr) 1995-09-26

Family

ID=22151834

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000573293A Expired - Fee Related CA1337115C (fr) 1987-07-30 1988-07-28 Vaccin contre les maladies apparentees a la rage

Country Status (3)

Country Link
EP (1) EP0326598A1 (fr)
CA (1) CA1337115C (fr)
WO (1) WO1989000861A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2645173B1 (fr) * 1989-03-29 1994-06-17 Pasteur Institut Clonage et expression de genes codant pour des peptides et/ou des fragments de peptides du virus mokola, application a la preparation d'un v
AU2359195A (en) * 1994-04-19 1995-11-10 Thomas Jefferson University Viral ribonucleocapsid as an immunological enhancer
CA2364150A1 (fr) * 2001-12-07 2003-06-07 Mireille Lafage Polypeptides induisant l'apoptose, polynucleotides les codant et leurs applications therapeuthiques
US9248179B2 (en) 2010-06-24 2016-02-02 The United States of America, as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Pan-lyssavirus vaccines against rabies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3683688D1 (de) * 1985-04-19 1992-03-12 Wistar Inst Impfstoff fuer die erzeugung einer gegen ein virus schuetzenden immunogenen t-zellen-antwort.
EP0237686A1 (fr) * 1986-03-18 1987-09-23 Institut Pasteur Séquences d'ADN dérivées du génome du virus de la rage

Also Published As

Publication number Publication date
EP0326598A1 (fr) 1989-08-09
WO1989000861A1 (fr) 1989-02-09

Similar Documents

Publication Publication Date Title
US5837249A (en) Method for generating an immunogenic T cell response protective against a virus
Dietzschold et al. Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein.
Perrin et al. Rabies immunosome (subunit vaccine) structure and immunogenicity. Pre-and post-exposure protection studies
JPH03502687A (ja) レスピラトリイ・シンシチアル・ウイルス：ワクチンおよび診断法
US20250262286A1 (en) Artificial promiscuous t helper cell epitopes that facilitate targeted antibody production with limited t cell inflammatory response
WO2024055273A1 (fr) Vaccin contre l'arnm de la rage et sa préparation et son utilisation
US12397050B2 (en) Universal mammalian influenza vaccine
US5824309A (en) Recombinant gas vesicles and uses thereof
Liew New aspects of vaccine development
JP4638880B2 (ja) アルキルホスファチジルコリン配合ワクチン組成物
WO1997020854A9 (fr) Vesicules gazeuses de recombinaison et leur utilisation
EP0326598A1 (fr) Vaccination contre des virus apparentes a la rage
EP1115382B1 (fr) Compositions liposomiques immunogeniques
AU608354B2 (en) Vaccination against rabies-related viruses
ES2379346T3 (es) Composiciones de vacuna combinadas de ADN/proteína
CA2090005C (fr) Immunisation croisee contre le virus de la grippe a
MXPA01010481A (es) Acidos nucleicos y polipeptidos de lisavirus quimerico.
Liew Biotechnology of vaccine development
Levi A synthetic approach to influenza vaccines
Ben-Yedidia A peptide-based vaccine against influenza
HK1039064B (en) Immunogenic liposome compositions
EP0547689A2 (fr) Peptides cycliques contenant un HIV PND cyclique et un épitope stimulant des cellules T
Pfeiffer Enhancing DNA vaccine-induced avian influenza hemagglutinin subtype-specific reference antisera production

Legal Events

Date Code Title Description
MKLA Lapsed